Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Hematologic Neoplasms
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Hematologic Neoplasms
Description
Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES. MeSH
Hierarchy View
Subtype Terms (1)
Bone Marrow Neoplasms
2 experimental drugs
Approved Indicated Drugs (2)
Phase 4 Indicated Drugs (22)
Phase 3 Indicated Drugs (26)
Other Experimental Indicated Drugs (5)
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (15)
Organization Involved with Phase 2 Indications (71)
Blueprint Medicines Corporation
Ciusss de L'Est de l'Île de Montréal
Hangzhou Zenshine Pharmaceuticals Co., Ltd.
Institut de Cancerologie Strasbourg Europe
Istituto Clinico Humanitas - Rozzano (MI), Italy
Moorgreen Hospital, Southampton
National Cancer Institute, France
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
Organization Involved with Phase 1 Indications (33)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
